Video

Elinor Ben-Menachem, MD

Publish date: May 5, 2015

At the 67th Annual Meeting of the AAN, Dr. Ben-Menachem reviews drug choices for new-onset epilepsy.

References

Recommended Reading

New Guideline Offers Advice for First Unprovoked Seizure

Epilepsy Resource Center

Seizure Onset Is Delayed After Intracranial Electrode Implantation

Epilepsy Resource Center

AAN/AES Guideline on Management of Unprovoked First Seizure in Adults

Epilepsy Resource Center

Medical Marijuana Liquid Extract May Help Children With Severe Epilepsy

Epilepsy Resource Center

Pediatric Epilepsy Surgeries Have Increased in the Past Decade

Epilepsy Resource Center

Conference Coverage

Seizures in dementia hasten decline and death
Publish date: December 14, 2022
Three antiseizure medications join list for newborn risks
Publish date: December 13, 2022
‘Striking’ rate of mental health comorbidities in epilepsy
Publish date: December 12, 2022
Significant racial disparities persist in status epilepticus
Publish date: December 12, 2022
Study implicates myelin plasticity in absence seizures
Publish date: December 9, 2022
Newer brand-name drugs fuel spending on antiseizure medications
Diazepam nasal spray effective in Lennox-Gastaut syndrome
Publish date: October 24, 2022
Antiseizure medication appears safe in pregnancy
Epilepsy in older adults: Misdiagnosis and case complexity are common
Don’t panic over lamotrigine, but beware of cardiac risks
Publish date: December 17, 2021

Multimedia

Patients describe significant impact of epilepsy on their lives
Tatiana Falcone, MD
Publish date: December 18, 2017
Andrew G. Herzog, MD
Publish date: December 18, 2017

Literature Review

Minorities with epilepsy blocked from receiving ‘highest quality of care’
Publish date: January 26, 2023
Modified Atkins diet beneficial in drug-resistant epilepsy
Publish date: January 10, 2023
Antiepileptic drugs tied to increased Parkinson’s disease risk
Publish date: January 3, 2023
Strong two-way link between epilepsy and depression
Publish date: December 6, 2022
High drug costs exclude most neurology patients from cutting-edge treatment
Drug-resistant epilepsy needs earlier surgical referral
‘Striking’ jump in cost of brand-name epilepsy meds
Air pollution is a seizure trigger for patients with epilepsy
New guidance on cannabis use for treatment-resistant epilepsy
ILAE offers first guide to treating depression in epilepsy

Neurobehavioral comorbidities of epilepsy

Question 1 of 5